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Introduction
Stress incontinence is a symptom or sign indicating
that the woman has involuntary urine loss associated with
exertion. Urodynamic stress incontinence (previously known
as genuine stress incontinence) is a solely urodynamic
diagnosis which occurs when an incompetent urethra allows
leakage of urine in the absence of a detrusor contraction.1
Rapid progress has been achieved in stress urinary
incontinence treatment after the description of minimally
invasive sling Tension free tape(TVT) in 1995 by Ulmsten,2
because of minimal morbidity and high initially success rate
and more than one million procedures have been performed
worldwide. The starting point for development of the TVT
procedure was the introduction of new pathophysiological
concepts of female stress urinary incontinence, known as the
"integral theory", by Petros and Ulmsten and Hammock
hypothesis by De Lancey.3,4 Both of these new hypothesis
shared the common concept that strong supportive sub
urethral tissue was essential for maintaining an adequate
continence mechanism in women. Restoration of the sub
urethral supportive tissue and increasing the urethral
resistance under stress condition were achieved by a specific
prolene tape in this procedure. High success rates reported in
mid and long-term studies has popularized this procedure, and
TVT-type procedures are gradually becoming the new gold
standard treatment for female stress urinary incontinence.5
The objectives of this retrospective study were to
assess subjective success rates, complications, and impact on
patient's quality of life (QoL) before and after the surgical
procedure in our setup.
Patients and Methods
A retrospective cohort analysis was conducted on 30
patients who had Tension free vaginal Tape alone or in
combination with other pelvic surgeries at Aga Khan
University Hospital, Karachi from June 2004 to October 2007.
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Abstract
Objectives: To assess subjective success rates, complications and impact on quality of life (QoL) in women
treated by Tension Free Vaginal Tape for urinary incontinence.
Methods: A retrospective cohort analysis was made on 30 consecutive women undergoing TVT procedure alone
or as concomitant to other pelvic surgical procedures, from June 2004 to October 2007.All the Patients were
evaluated by history, clinical examination with POP-Q(pelvic organ prolapse-quantification) scoring for
uterovaginal prolapse and urodynamic testing. Improvement of health -related QoL (quality of life) was assessed
by incontinence impact questionnaire-short form (IIQ-7) and urogenital distress inventory -short form (UDI-6).The
success of surgery was evaluated by asking whether the incontinence was cured, improved or had no change
after the operation. Data was computed and analyzed by using SPSS version 13.
Results: Concomitant surgery was performed in 14 (46.6%) cases. Median age was 47 years and duration of
follow up was 14 months (range 4-37 months). Eight (26.6%) women had mixed Urinary Incontinence with
Detrusor Overactivity. Previous pelvic surgery like MMK (Marshall-Marchetti-Krantz along with TAH (total
abdominal hysterectomy) was found in 5 (16.6%) cases. Complications were listed as per-operative, short term
and long-term. Among the short term complications Bladder perforation was seen in 2 cases (6.7%) and overt
urinary retention in 2 cases (6.7%). Long-term complications as voiding dysfunction occurred in only 1(3.3%) case.
Symptoms were labeled as completely cured in 27 (90%) patients, significantly improved in 2(6.6%) and one with
mixed incontinence regarded as having worsening of urge symptoms and dysuria.
Conclusion: A median follow up of 14 months showed that our surgical results of TVT alone or with concomitant
surgery were similar to internationally published results and TVT can be safely performed with concomitant
procedures (JPMA 59:274; 2009).
The initial pre-operative evaluation included a history,
clinical examination with POP-Q (pelvic organ prolapse-
quantification) scoring for uterovaginal prolapse and
urodynamic testing.1 All of the above had an objective
assessment of symptoms by stress test and urodynamic stress
incontinence. All the women had a negative urine culture
before the urodynamic testing and eight women with
concomitant urinary urge incontinence gave a 24 hours record
of urinary diary as well.Urodynamic stress incontinence was
seen as observation of urinary leak with rise of valsalva leak
point pressure> 60 cm water in 25 women (urethral hyper
mobility) while five women showed a low leak point pressure
<60 cm water (Intrinsic sphincter defect). Detrusor over
activity was also recorded in 8 women (mixed UI).
Improvement of health-related QoL was assessed by
incontinence impact questionnaire-short form (IIQ-7) and
urogenital distress inventory -short form (UDI-6).6 Response
to each item were originally rated between 0 (not affected at
all) and 3 (greatly affected). Post operatively IIQ-7 and UDI-
6 were re-evaluated along with objective assessment by stress
test at each follow up visit. Patients were advised to have visits
after one, 4, 8 and 12 weeks. Women having more than 3
months duration of surgery and no further follow up visits and
were interviewed by Telephone. 
Criteria for Cure:
The success of surgery was evaluated by asking
whether the incontinence was cured, improved or had no
change after the operation. We also questioned if urinary
urgency worsened or appeared de-novo after the procedure.
Voiding dysfunction was defined as having dysuria
and inability to void or post void residual >200 ml requiring a
Foleys catheter or intermittent self catheterization at discharge
from hospital. Postoperatively the patients were regarded as
cured if they had negative stress test results and if QoL had
improved > 90%.To be regarded as improved the patient had
to have a > 75 improved QoL. Data analysis was performed
using statistical program SPSS version 14. Descriptive
statistics were presented as a percentage of the total numbers.
Results
Patient characteristics are shown in Table 1. All the
patients were assessed by POP-Q scoring for uterovaginal
prolapse and 16 patients had minor degree of prolapse (stage
1 and 2) while 6 patients had major degree of prolapse (stage
3 and 4). Median duration of follow up was 14 months (4-37).
TVT alone patients were discharged after 24 hours of surgery
and mean duration of stay with concomitant surgery was 3
days. Fifteen women were menopausal and 10 were using
local application of estrogen vaginal cream. 
Table 2 shows the types of surgery performed.
Concomitant surgery was performed in 14 women (70%).
These procedures included: posterior vaginal repair,9 vaginal
sacropexy1 and vaginal hysterectomy with anterior and
posterior vaginal repair1 and with pelvic floor repair.3
Complications are shown in Table 3. Bladder
perforation occurred in two patients. Urinary retention
occurred in 2 cases. 
All the patients received only prophylactic antibiotic
but one patient with concomitant surgery developed acute UTI
and was treated by therapeutic antibiotics. Long term follow
up showed voiding dysfunction   in only one patient.
No patient so far complained of de-novo urinary
urgency and with median follow up for 16 months (range 4-
37months) no patient has shown any signs of tape infection
/erosion or tape rejection. All of the patients had a negative
stress test soon after surgery and during subsequent visits.
During the first 3 months post-operatively results and QoL had
improved > 90% in 27 patients (90%) and > 75% in 2 patients
(6.6%) while in one patient (3.3%) there was voiding
dysfunction which persisted after 6 months of surgery.
Discussion
Several reports have been published claiming that
TVT (tension free vaginal tape) is a safe and effective
treatment for female urinary incontinence.7,8
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Table 1: Patient characteristics. (n=30).
Age (years) 47 (30-74)
Parity 4 (2-9)
BMI 30(23-40)
Menopausal 50%
Urge symptoms (pre-operative) 36.7%
Duration of incontinence symptoms (years) 5.5(1-20)
Follow -up time (months) 14(4-37)
Previous pelvic surgery 5(16.6%)
Recurrent UTI 3(10%)
POP-Q     stage o 8(26.6%)
POP-Q     stage 1 7(23.3%)
POP-Q    stage 2 9(30%)   
POP-Q    stage 3 2(6.7%)
POP-Q    stage 4 4(13%) 
*Values are given as median (range) or percent.
Table 2: Types of surgery performed (n=30).
Variable n %
TVT surgery alone 16 53.3%
TVT and Posterior repair 9 30.3%
TVT, Vaginal hysterectomy
and pelvic Floor repair 3 10.0%
Vaginal hysterectomy and
anterior and posterior repair 1 3.3%
TVT and Sacropexy repair 1 3.3%
TVT = Tension Free Vaginal Tape.
Our objective success rate by stress test and subjective
success rates by IIQ-7 scoring at 4, 8 and 12 weeks showed >
90% improvement in symptoms in 27 (90%) patients and >
75% improvement in symptoms in 2 (6.6%) patients while in
one patient (3.3%) there was long term voiding dysfunction.
There is no local study for comparison; the Ward/Hilton trial9
measured both objective and subjective cure at 6 months, one
year and 2 year. Subjective cure of stress incontinence
amongst those assessed at 6 months was 65%, the rates for
objective cure varied between 65 and 95% and all the patients
were subjected to urodynamic testing post-operatively.9Using
both the subjective and objective assessment criteria, the long-
term results after 5 years by Nilsson et al showed 84.7%
patients as completely cured, 10.6% had significantly
improved and 4.7% were regarded as failures.10
Bladder perforation rate has been reported to be
between 1.1 and 15% after TVT procedures.11 No consensus
exists on concomitant surgery as being a risk factor for
postoperative urinary retention and bladder perforation.11
Bladder perforation occurred in only 2 (6.7%) patients.
One patient had TVT and posterior repair, with Body Mass
Index of 40 and hence obesity can be considered as another
risk factor for bladder perforation. Another patient had only
TVT but she had previous two Caesarean Sections and one
difficult abdominal hysterectomy. The results of the studies
regarding previous pelvic surgery as a risk factor for bladder
perforation are conflicting12,13 as the numbers are relatively
very small, and it is not possible to derive any meaningful
results regarding these risk factors. 
The coexisting rate of stress urinary incontinence in
patients having a prolapse is as high as 63%.14 We
performed 14 TVT procedures in combination with
hysterectomy, hysteropexy and posterior colporraphy and
pelvic floor repair.
Short-term voiding disorder is described in 4% to 11 %
of women and retention requiring transaction of tape occurs in
1% to 2.8%.15A multi-institutional review has shown urinary
retention (>24 hours after) in 19.7% of women16 while a
retrospective controlled study by Tayrac et al showed urinary
retention in 46.2% of patients having concomitant surgery
with TVT within first seven days and in 11.5% after the first
week.17The cure rate for stress urinary incontinence with TVT
and concomitant surgery was 96.2%.
Long-tern voiding dysfunctions like urgency and
dysuria persisted for >12 weeks in one patient with history of
Marshal Marchetti Krantz surgery in the past. She was
diagnosed as having mixed urinary incontinence and recurrent
UTI as well. The incidence of mixed UI ranges from 30% to
50%. Duckett and Tamilselvi have shown subjective cure of
urge symptoms in 63% women of mixed UI following TVT
while overactive bladder symptoms persisted in 37%.18 For
post-operative overactive bladder symptoms prior to anti-
incontinence surgery and old age were found to be possible
risk factors.11
A relatively low rate of complications is an important
advantage of the TVT-type procedure. The incidence of
intraoperative blood loss of over 200 cc was reported as
1.9%, major vessel injury, 0.07% and vaginal haematoma
0.07%.19 Fortunately we did not encounter any case of intra-
operative haemorrhage or post-operative vaginal haematoma
and this could be related to the use of general or regional
anaesthesia. Wang, in his article has commented that a
possibility with light sedation is that some patients can
become agitated and not cooperate with the surgeon during
trocar insertion, in which case persistent attempts to pass the
trocar could result in bladder perforation or even a laceration
of the external iliac vessels.20
After TVT procedure, 4.1, 0.8 and 0.7% of the
patients had urinary tract infection, wound infection of
abdominal incision and defective healing of vaginal
incision, respectively.21 One of our patient (3.3%) after TVT
and vaginal hysterectomy developed urinary tract infection
and Tayrac et al have reported postoperative urinary
infection in 11.5% in patients with concomitant surgery vs
4.5% in patients with TVT alone (p>0.05).17
None of our patients developed mesh infection or
showed urethral and vaginal erosions over a median follow
up of 14 months (range4-37 months) and this could be due
to relatively younger age group, median age 47 (range 30-
74 years).
Conclusion
Although we have a small and short term data but our
results are comparable to those published by Western
countries. Our results indicate that TVT is a safe and effective
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Table 3: Procedures Complications.
Complications n %
I. Per-operative   
Haemorrhage 0 0
Bladder perforation 2.0 6.7%
II. Short term complications 2 6.7%
Urinary retention UTI 1 3.3%
Voiding dysfunction
(dysuria with retention)
III. Long term complications Voiding 1 3.3%
dysfunction 0 0%
De-novo urgency 0 0%
Urethral and vaginal erosions
treatment for stress urinary incontinence and concomitant
surgeries can be safely performed. The women in the study
had a median age of 47 years and hence no age-related
complications like mesh infection, erosion and De novo
urgency were observed. All patients were assessed
objectively and subjectively for urinary incontinence pre-
operatively but post-operatively only subjective was done.
The objective assessment was made by cough test. A
prospective study with post-operative objective assessment
by urodynamic testing is warranted.
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